Welcome to Noselab. With its rapidly increasing number of patients, Alzheimer's is considered as one of the most common diseases worldwide. So far, the diagnosis of Alzheimer's is complex, expensive and happens at a later stage in the course of the disease. That’s why early detection is one, if not the key component for coming up with better and more effective treatments. We are focusing on the nose as interface to our frontal brain and we are targeting the challenges of Alzheimer's by developing a novel, ground-breaking test based on the analysis of nasal secretion to support the diagnosis. We complement this diagnostic solution with a data-driven medicine approach leveraging AI-based methods to generate insights to improve personalised treatments and drug development. Our vision is to drive a paradigm shift in diagnosis, understanding and treatment of Alzheimer's to significantly improve patients’ lives. Interested to join our team? Contact us.